☆ 4.6 Review

Exposure to medication for neurological disease in pregnancy - time to consider the long-term implications?

ECLINICALMEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Adaptive behaviour in children exposed to topiramate in the womb: An observational cohort study

R. Knight et al.

Summary: This study investigated the adaptive behavior outcomes in children exposed to topiramate in the womb and found that exposure to topiramate is associated with poorer adaptive behavior, higher incidence of Autism Spectrum Disorder, and significant associations with birth weight. These findings require further validation and replication using larger samples.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2023)

Add to Collection

Article Rheumatology

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

John A. Reynolds et al.

Summary: This study investigated the outcomes of children born to mothers with SLE exposed to HCQ or AZA during pregnancy. The results showed that there were no significant negative outcomes in children exposed to HCQ during pregnancy. However, the use of AZA was associated with an increased reporting of childhood infection, which requires further study.

RHEUMATOLOGY (2023)

Add to Collection

Article Clinical Neurology

Family planning considerations in people with multiple sclerosis

Kristen M Krysko et al.

LANCET NEUROLOGY (2023)

Add to Collection

Review Allergy

Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective

Yiyi Luo et al.

Summary: The neonatal immune system develops during pregnancy to prepare the newborn for life outside the womb. It prioritizes certain immune responses to prevent excessive inflammation and ensure immune tolerance and homeostasis. Exposure to immune modulatory drugs during pregnancy can affect the development of the fetal immune system.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

R. L. Bromley et al.

Summary: The study aims to achieve consensus on the core neurodevelopmental outcomes, optimize methodologies, and overcome barriers in conducting pregnancy pharmacovigilance studies with neurodevelopmental outcomes. The vision is to establish a comprehensive understanding of neurodevelopmental outcomes in pregnancy pharmacovigilance through a complementary set of studies.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Antenatal corticosteroids to reduce neonatal morbidity and mortality Green-top Guideline No. 74

S. J. Stock et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Add to Collection

Article Clinical Neurology

Antiseizure Medication Concentrations During Pregnancy Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study

Page B. Pennell et al.

Summary: This study aims to characterize the changes in concentration of antiseizure medications during pregnancy. The results show that dose-normalized concentrations during pregnancy are significantly decreased compared to postpartum values, suggesting the need for increasing doses of these medications throughout pregnancy.

JAMA NEUROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy

Kerstin Hellwig et al.

Summary: This prospective cohort study found that 10% of women may retain clinically meaningful disability from pregnancy-related natalizumab cessation relapses 1 year post partum. This information should be shared with women on natalizumab who desire pregnancy to weigh the high risk of pregnancy-related relapses and disability to the partly uncertain risks of continuing natalizumab throughout pregnancy or switching to depleting agents before conception.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Public, Environmental & Occupational Health

A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project

Roque Pereira Leonardo et al.

Summary: A large proportion of medicine product labels lack safety information for pregnancy and breastfeeding. The current process of generating evidence in these areas is inefficient and has little impact. A redesign is needed to support evidence-based decision making.

DRUG SAFETY (2022)

Add to Collection

Review Clinical Neurology

The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review

Sierra J. Vig et al.

Summary: This article reports a case of a woman who continued to use erenumab for migraine prophylaxis during pregnancy and reviews the limited pregnancy safety data for CGRP receptor and ligand-directed therapies approved for migraine prophylaxis. The findings highlight the lack of safety data regarding the use of these agents during pregnancy, despite their frequent use in women of childbearing potential.

HEADACHE (2022)

Add to Collection

Article Clinical Neurology

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

Marte-Helene Bjork et al.

Summary: This study found that prenatal exposure to antiseizure medication is associated with an increased risk of neurodevelopmental disorders in children, especially when exposed to topiramate, valproate, and certain duotherapies.

JAMA NEUROLOGY (2022)

Add to Collection

Review Pediatrics

Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids A Systematic Review and Meta-analysis

Kiran Ninan et al.

Summary: This study conducted a systematic review and meta-analysis to investigate the long-term outcomes associated with preterm exposure to antenatal corticosteroids in children. The findings suggest that while a single course of antenatal corticosteroids may reduce the risk of neurodevelopmental impairment in extremely preterm infants, it is associated with an increased risk of adverse neurocognitive and/or psychological outcomes in children born late-preterm and full-term. These findings highlight the need for caution in administering antenatal corticosteroids.

JAMA PEDIATRICS (2022)

Add to Collection

Article Clinical Neurology

Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population

Johanna Balslev Andersen et al.

Summary: The study investigated the association of adverse perinatal outcomes in newborns with maternal or paternal exposure to teriflunomide, and found no increased prevalence of spontaneous abortion, preterm birth, congenital malformations, low Apgar score, or being small for gestational age in newborns with exposure to teriflunomide compared to the general population.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Add to Collection

Article Medicine, General & Internal

Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring

Gerd Marie Harris et al.

Summary: The findings of this study suggest that prenatal exposure to triptans is not associated with an increased risk of ADHD among offspring.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Clinical Neurology

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

Doriana Landi et al.

Summary: The study found that continuing natalizumab treatment throughout pregnancy and resuming it early after delivery can reduce the risk of clinical and radiological reactivation in women with multiple sclerosis. This approach has no major impact on newborns' outcomes.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Add to Collection

Review Clinical Neurology

Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force

Torbjorn Tomson et al.

Summary: This article summarizes the findings of a systematic review on the transfer of antiseizure medications (ASMs) into breastmilk, ASM serum concentrations in breastfed infants, and the wellbeing of infants breastfed by mothers on ASM treatment. The review found limited data on certain medications, but overall, breastfeeding appears to be safe for infants regardless of the type of ASM. However, further long-term studies are needed to draw firm conclusions on the developmental outcomes of breastfed infants.

EPILEPTIC DISORDERS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Neurodevelopmental outcomes in children exposed prenatally to levetiracetam

Bshra A. Alsfouk

Summary: Some old antiseizure medications may pose risks to fetal development, leading to physical birth abnormalities and neurodevelopmental delay. Therefore, there is a trend towards using new antiseizure medications during pregnancy, particularly lamotrigine and levetiracetam, due to their lower risk of birth abnormalities. Lamotrigine has been extensively studied for its neurodevelopmental effects, while there is limited data on the effects of levetiracetam.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2022)

Add to Collection

Article Oncology

Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero

Rebecca Clark et al.

Summary: Rituximab, an antibody increasingly used during pregnancy, can lead to various clinical presentations in newborns. This case is the first to report the long-term care experience of an infant with severe neutropenia and prolonged hypogammaglobulinemia after exposure to rituximab in utero.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)

Add to Collection

Article Clinical Neurology

Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study

Emmanuelle Pauliat et al.

Summary: This study investigated pregnancy outcomes after fingolimod use for multiple sclerosis, comparing them with interferon-beta-exposed pregnancies. It found a slightly higher rate of major congenital anomalies in the fingolimod group, but further studies are needed to definitively rule out this risk.

MULTIPLE SCLEROSIS JOURNAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life

Shannon Linda Kanis et al.

Summary: This study aimed to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and assess the impact of maternal IBD medication use on these outcomes. The results showed no association between in utero exposure to anti-TNF-alpha and/or thiopurine and long-term health outcomes, but an increased rate of intrahepatic cholestasis of pregnancy (ICP) was found when thiopurine was used during pregnancy.

GUT (2021)

Add to Collection

Article Clinical Neurology

Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database

Roberta Noseda et al.

Summary: The study assessed the safety profile of erenumab, galcanezumab, and fremanezumab during pregnancy and lactation. Although no specific maternal toxicities or major birth defects were found, continuous surveillance is necessary due to the limited number of reported adverse reactions and lack of long-term safety data.

CEPHALALGIA (2021)

Add to Collection

Review Pediatrics

School-aged neurodevelopmental outcomes for children born extremely preterm

Lex W. Doyle et al.

Summary: With improvements in medical care, survival rates for extremely preterm infants have increased, but they face more health and developmental challenges during school-age years.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Add to Collection

Review Medicine, General & Internal

The use and impact of monoclonal antibody biologics during pregnancy

Anne Pham-Huy et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Add to Collection

Review Neurosciences

Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review

Rebecca L. Bromley et al.

Summary: Research on the effects of exposure to antiseizure medications during pregnancy has been ongoing for a long time, but more data is needed for conclusions on the impact of drugs other than valproate. Current focus is mainly on phenobarbital, phenytoin, and lamotrigine, with limited data available for levetiracetam, topiramate, and oxcarbazepine. Improvements in focus, funding, and research methodologies are urgently needed.

CURRENT NEUROPHARMACOLOGY (2021)

Add to Collection

Review Clinical Neurology

Diagnosis and management of migraine in ten steps

Anna K. Eigenbrodt et al.

Summary: Migraine is a common but often under-diagnosed and under-treated condition. The Consensus Statement provides guidelines for diagnosis and management, emphasizing the importance of patient education and patient-centered care.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results

Sandra Thiel et al.

Summary: The German MS and Pregnancy Registry (DMSKW) is a nationwide observational cohort study focusing on pregnant women with MS or NMOSD. By December 2020, the database included 2579 pregnancies, with 76% exposed to DMT during pregnancy. Data showed that 19% of women experienced at least one relapse during pregnancy, particularly during the third trimester.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Psychology, Clinical

Associations of antenatal glucocorticoid exposure with mental health in children

Elina Wolford et al.

PSYCHOLOGICAL MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease

Brindusa Truta et al.

INFLAMMATORY BOWEL DISEASES (2020)

Add to Collection

Review Immunology

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

Cristina Belizna et al.

AUTOIMMUNITY REVIEWS (2020)

Add to Collection

Article Clinical Neurology

Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy

Angela K. Birnbaum et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children

Katri Raikkonen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Clinical Neurology

Rituximab, MS, and pregnancy

Jessica B. Smith et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Add to Collection

Review Clinical Neurology

Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases

Sara C. LaHue et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Add to Collection

Article Gastroenterology & Hepatology

In uteroexposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark

Bente Mertz Norgard et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France

Joel Coste et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Medicine, General & Internal

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones

Christine Aarenstrup Daugaard et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Clinical Neurology

OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients

Ho-Tin Wong et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Add to Collection

Article Obstetrics & Gynecology

Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes

Ashley N. Battarbee et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2020)

Add to Collection

Article Gastroenterology & Hepatology

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Longterm Outcome of Exposed Children: A Controlled, Multicenter Observation

Dana Duricova et al.

INFLAMMATORY BOWEL DISEASES (2019)

Add to Collection

Editorial Material Clinical Neurology

The global burden of neurological disorders

William M. Carroll

LANCET NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Valery L. Feigin et al.

LANCET NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Headache in Pregnancy and the Puerperium

Rebecca Burch

NEUROLOGIC CLINICS (2019)

Add to Collection

Article Genetics & Heredity

Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability

Jill Clayton-Smith et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Add to Collection

Article Obstetrics & Gynecology

Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study

Ambrogio P. Londero et al.

BMC PREGNANCY AND CHILDBIRTH (2019)

Add to Collection

Article Clinical Neurology

Natalizumab during pregnancy and lactation

Undine Proschmann et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Add to Collection

Article Clinical Neurology

Natalizumab during pregnancy and lactation

Undine Proschmann et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Add to Collection

Article Clinical Neurology

Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations

Michael O. Kinney et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: Follow-up from the Norwegian Mother and Child Cohort Study

Gerd-Marie Eskerud Harris et al.

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants

Michael G. Kattah et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)

Add to Collection

Article Clinical Neurology

Verbal abilities in children of mothers with epilepsy Association to maternal folate status

Elisabeth Synnove Nilsen Husebye et al.

NEUROLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Neurodevelopmental Effects of Antiepileptic Drugs

Marissa Kellogg et al.

NEUROCHEMICAL RESEARCH (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study

Mollie E. Wood et al.

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect

Cesar G. Victora et al.

LANCET (2016)

Add to Collection

Article Medicine, General & Internal

Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study

Mollie E. Wood et al.

BMJ OPEN (2016)

Add to Collection

Review Clinical Neurology

Pregnancy Outcome Following Prenatal Exposure to Triptan Medications: A Meta-Analysis

Alexander Marchenko et al.

HEADACHE (2015)

Add to Collection

Article Nursing

Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis

Teresa E. Baker et al.

JOURNAL OF HUMAN LACTATION (2015)

Add to Collection

Article Clinical Neurology

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

Neda Ebrahimi et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

Add to Collection

Article Clinical Neurology

IQ at 6 years after in utero exposure to antiepileptic drugs A controlled cohort study

Gus A. Baker et al.

NEUROLOGY (2015)

Add to Collection

Article Rheumatology

The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes

C. Nalli et al.

LUPUS (2014)

Add to Collection

Article Public, Environmental & Occupational Health

Topiramate use in pregnancy and the birth prevalence of oral clefts

Daniel Mines et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)

Add to Collection

Article Pediatrics

Breastfeeding in Children of Women Taking Antiepileptic Drugs Cognitive Outcomes at Age 6 Years

Kimford J. Meador et al.

JAMA PEDIATRICS (2014)

Add to Collection

Article Gastroenterology & Hepatology

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

T. G. J. de Meij et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)

Add to Collection

Article Clinical Neurology

Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review

Yara D. Fragoso et al.

CNS DRUGS (2013)

Add to Collection

Review Endocrinology & Metabolism

Early-Life Glucocorticoid Exposure: The Hypothalamic-Pituitary-Adrenal Axis, Placental Function, and Longterm Disease Risk

Thorsten Braun et al.

ENDOCRINE REVIEWS (2013)

Add to Collection

Article Clinical Neurology

Exposure to antiepileptic drugs in utero and child development: A prospective population-based study

Gyri Veiby et al.

EPILEPSIA (2013)

Add to Collection

Article Nursing

Epilepsy in Pregnancy Best Evidence for Care

Donna Jean Ruth et al.

JOURNAL OF PERINATAL & NEONATAL NURSING (2013)

Add to Collection

Article Clinical Neurology

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Kimford J. Meador et al.

LANCET NEUROLOGY (2013)

Add to Collection

Article Obstetrics & Gynecology

Use of topiramate in pregnancy and risk of oral clefts

Andrea V. Margulis et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)

Add to Collection

Article Clinical Neurology

Utilization of Topiramate During Pregnancy and Risk of Birth Defects

Mark W. Green et al.

HEADACHE (2012)

Add to Collection

Article Obstetrics & Gynecology

Obstetric outcome in women with epilepsy: a hospital-based, retrospective study

I. Borthen et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)

Add to Collection

Article Hematology

Pregnancy outcomes after maternal exposure to rituximab

Eliza F. Chakravarty et al.

BLOOD (2011)

Add to Collection

Article Pharmacology & Pharmacy

Delivery Outcome after Maternal Use of Drugs for Migraine

Bengt Källén et al.

DRUG SAFETY (2011)

Add to Collection

Article Behavioral Sciences

Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure

Kimford J. Meador et al.

EPILEPSY & BEHAVIOR (2011)

Add to Collection

Article Gastroenterology & Hepatology

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

Kuldeep Cheent et al.

JOURNAL OF CROHNS & COLITIS (2010)

Add to Collection

Article Clinical Neurology

Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome

Kirsti Haaland

JOURNAL OF HEADACHE AND PAIN (2010)

Add to Collection

Article Clinical Neurology

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

M. P. Amato et al.

NEUROLOGY (2010)

Add to Collection

Article Developmental Biology

Early Pregnancy Azathioprine Use and Pregnancy Outcomes

Brian J. Cleary et al.

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2009)

Add to Collection

Article Obstetrics & Gynecology

Antidepressant Use During Pregnancy: Current Controversies and Treatment Strategies

Jennifer L. Payne et al.

CLINICAL OBSTETRICS AND GYNECOLOGY (2009)

Add to Collection

Review Clinical Neurology

Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts

Kimford Meador et al.

EPILEPSY RESEARCH (2008)

Add to Collection

Article Clinical Neurology

Topiramate in pregnancy - Preliminary experience from the UK epilepsy and pregnancy register

S. Hunt et al.

NEUROLOGY (2008)

Add to Collection

Article Reproductive Biology

Calcitonin gene-related peptide (CALCA) is a proangiogenic growth factor in the human placental development

Yuan-Lin Dong et al.

BIOLOGY OF REPRODUCTION (2007)

Add to Collection

Article Obstetrics & Gynecology

Pharmacokinetics of corticosteroids during pregnancy

Luis D. Pacheco et al.

AMERICAN JOURNAL OF PERINATOLOGY (2007)

Add to Collection

Article Urology & Nephrology

Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the renin-angiotensin system

Mireille Lacoste et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Add to Collection

Review Clinical Neurology

Migraine during pregnancy - Options for therapy

AW Fox et al.

CNS DRUGS (2005)

Add to Collection

Article Clinical Neurology

Normal intelligence in children with prenatal exposure to carbamazepine

E Gaily et al.

NEUROLOGY (2004)

Add to Collection

Article Cardiac & Cardiovascular Systems

Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone

YL Dong et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)

Add to Collection

Review Endocrinology & Metabolism

Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity

C Yallampalli et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)

Add to Collection

Article Clinical Neurology

Additional educational needs in children born to mothers with epilepsy

N Adab et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.